The BRAF gene is frequently mutated in malignant melanoma
Stratton, M.R.; Wooster, R.W.; Futreal, P.A.
Journal of Drugs in Dermatology Jdd 3(5): 573-575
2004
ISSN/ISBN: 1545-9616 PMID: 15552615 Document Number: 10024
Document emailed within 1 workday
Related Documents
Mihic-Probst, D.; Perren, A.; Schmid, S.; Saremaslani, P.; Komminoth, P.; Heitz, P.U. 2004: Absence of BRAF gene mutations differentiates spitz nevi from malignant melanoma Anticancer Research 24(4): 2415-2418Tsujimoto, T.; Mochizuchi, S.; Iwadate, Y.; Namba, H.; Nagai, M.; Kawamoto, T.; Sunahara, M.; Yamaura, A.; Nakagawara, A.; Sakiyama, S.; Tagawa, M. 2000: The p73 gene is not mutated in oligodendrogliomas which frequently have a deleted region at chromosome 1p36.3 Anticancer Research 20(4): 2495-2497
Miura, T.; Ishikawa, S. 1970: Malignant melanoma--synopses from the seminar on malignant melanoma by International Group for the Clinical Study of Melanoma Gan no Rinsho. Japan Journal of Cancer Clinics 16(11): 1064-1070
Takahashi, M.; Fukuda, K.; Sugimura, T.; Wakabayashi, K. 1998: Beta-catenin is frequently mutated and demonstrates altered cellular location in azoxymethane-induced rat colon tumors Cancer Research 58(1): 42-46
Zanna, P.; Maida, I.; Grieco, C.; Guida, S.; Turpin Sevilla, M.C.; De Summa, S.; Tommasi, S.; Vena, G.A.; Filotico, R.; Guida, G. 2013: Three novel human sporadic melanoma cell lines: signaling pathways controlled by MC1R, BRAF and β-catenins Journal of Biological Regulators and Homeostatic Agents 27(1): 131-141
Lewis, D.C.; Warren, N.; Shukla, V.K.; Grimshaw, D.; Laidler, P.; Padua, R.A. 1993: Gross rearrangements and deletions of the retinoblastoma gene are rare in malignant melanoma Acta Dermato-Venereologica 73(3): 236
Trent, J.M.; Bittner, M.; Zhang, J.; Wiltshire, R.; Ray, M.; Su, Y.; Gracia, E.; Meltzer, P.; De Risi, J.; Penland, L.; Brown, P. 1997: Use of microgenomic technology for analysis of alterations in DNA copy number and gene expression in malignant melanoma Clinical and Experimental Immunology 107(Suppl): 33-40
Shannan, B.; Seifert, M.; Leskov, K.; Boothman, D.; Pföhler, C.; Tilgen, W.; Reichrath, J. 2006: Clusterin (CLU) and melanoma growth: CLU is expressed in malignant melanoma and 1,25-dihydroxyvitamin D3 modulates expression of CLU in melanoma cell lines in vitro Anticancer Research 26(4a): 2707-2716
Mirsky, R.; Prado, G.; Svoboda, R.; Glazer, A.; Rigel, D. 2018: Management Decisions Made by Physician Assistants and Nurse Practitioners in Cutaneous Malignant Melanoma Patients: Impact of a 31-Gene Expression Profile Test Journal of drugs in dermatology: JDD 17(11): 1220-1223
Samowitz, W.S.; Thliveris, A.; Spirio, L.N.; White, R. 1995: Alternatively spliced adenomatous polyposis coli (APC) gene transcripts that delete exons mutated in attenuated APC Cancer Research 55(17): 3732-3734
Spandidos, D.A. 1986: The human T24 Ha-ras1 oncogene: a study of the effects of overexpression of the mutated ras gene product in rodent cells Anticancer Research 6(2): 259-262
Kiyohara, Y.; Yoshikawa, S.; Fujiwara, N.; Otsuka, M.; Nakagawa, M.; Yamamoto, A.; Saida, T. 2005: Sentinel node navigation surgery in melanoma and non-melanoma malignant skin tumor Gan to Kagaku Ryoho. Cancer and ChemoTherapy 32(8): 1191-1194
Monti, M.; Berti, E.; Cavicchini, S.; Paindelli, M.G.; Terragni, L. 1985: Identification of protein S 100 and melanoma-associated antigens in a comparative study of malignant melanoma and nevus pathology Giornale Italiano di Dermatologia e Venereologia: Organo Ufficiale Societa Italiana di Dermatologia e Sifilografia 120(4): 297-306
Muto, M.; Saito, Y.; Koike, T.; Yamagiwa, Y.; Iijima, K.; Ikeya, S.; Sasaki, T.; Nakayama, H.; Hoshino, E.; Sugai, Y.; Tajiri, H.; Nishihira, T. 1997: Primary malignant melanoma of the esophagus with diffuse pigmentation resembling superficial spreading melanoma American Journal of Gastroenterology 92(10): 1936-1937
Klein-Szanto, A.J.; Silvers, W.K.; Mintz, B. 1994: Ultraviolet radiation-induced malignant skin melanoma in melanoma-susceptible transgenic mice Cancer Research 54(17): 4569-4572
Gorelik, E.; Jay, G.; Kim, M.; Hearing, V.J.; DeLeo, A.; McCoy, J.P. 1991: Effects of H-2Kb gene on expression of melanoma-associated antigen and lectin-binding sites on BL6 melanoma cells Cancer Research 51(19): 5212-5218
Frydland, M.; Elming, H.; Ahlehoff, O. 2014: Malignant melanoma with metastatic melanoma to the heart Ugeskrift for Laeger 176(25)
Castelli, C.; Sensi, M.; Lupetti, R.; Mortarini, R.; Panceri, P.; Anichini, A.; Parmiani, G. 1994: Expression of interleukin 1 alpha, interleukin 6, and tumor necrosis factor alpha genes in human melanoma clones is associated with that of mutated N-RAS oncogene Cancer Research 54(17): 4785-4790
Ikeda, S.; Ishihara, K.; Taguchi, G. 1985: Phase IIi study of bestatin in patients with malignant skin tumors. (1) Malignant melanoma Gan to Kagaku Ryoho. Cancer and ChemoTherapy 12(1): 77-85
Ashmarin, I.I.; Khazanov, A.I.; Ivlev, A.S.; Naĭdenov, I.N.; Zhuravlev, A.P. 1982: Case of a malignant apudoma showing double differentiation in metastases of melanoma and malignant carcinoid types Vestnik Dermatologii i Venerologii 5: 41-44